Skip Navigation
About   Site Map   Contact Us
A service of the U.S. National Library of Medicine®
Printer-friendly version
Cerebrotendinous xanthomatosis
 Quick links to this topic
 Health information
 National Institutes of Health
 Information pages
 For patients and families
 Clinical summary
 DNA test labs
 Recent literature
 Medical and science texts
 Genetic disorder catalog

Cerebrotendinous xanthomatosis

Reviewed March 2008

What is cerebrotendinous xanthomatosis?

Cerebrotendinous xanthomatosis is a fat (lipid) storage disorder that affects many areas of the body. People with this disorder cannot break down certain lipids effectively, specifically different forms of cholesterol, so these fats accumulate in various areas of the body. Xanthomatosis refers to the formation of fatty yellow nodules (xanthomas). Cerebrotendinous refers to the typical locations of the xanthomas (cerebro- meaning the brain and -tendinous meaning connective tissue called tendons that attach muscle to bone).

Other features of cerebrotendinous xanthomatosis include chronic diarrhea during infancy, clouding of the lens of the eye (cataracts) developing in late childhood, progressively brittle bones that are prone to fracture, and neurological problems in adulthood, such as dementia, seizures, hallucinations, depression, and difficulty with coordinating movements (ataxia) and speech (dysarthria). The neurological symptoms are thought to be caused by an accumulation of fats and an increasing number of xanthomas in the brain. Xanthomas can also accumulate in the fatty substance that insulates and protects nerves (myelin), disrupting nerve signaling in the brain. Disorders that involve the destruction of myelin are known as leukodystrophies. Degeneration (atrophy) of brain tissue caused by excess lipid deposits also contributes to the neurological problems.

Xanthomas in the tendons (most commonly in the Achilles tendon, which connects the heel of the foot to the calf muscles) begin to form in early adulthood. Tendon xanthomas may cause discomfort and interfere with tendon flexibility. People with cerebrotendinous xanthomatosis are also at an increased risk of developing cardiovascular disease. If untreated, the signs and symptoms related to the accumulation of lipids throughout the body worsen over time; however, the course of this condition varies greatly among those who are affected.

How common is cerebrotendinous xanthomatosis?

The incidence of cerebrotendinous xanthomatosis is estimated to be 3 to 5 per 100,000 people worldwide. This condition is more common in the Moroccan Jewish population with an incidence of 1 in 108 individuals.

What genes are related to cerebrotendinous xanthomatosis?

Mutations in the CYP27A1 gene cause cerebrotendinous xanthomatosis. The CYP27A1 gene provides instructions for producing an enzyme called sterol 27-hydroxylase. This enzyme works in the pathway that breaks down cholesterol to form acids used in the digestion of fats (bile acids). Mutations in sterol 27-hydroxylase impair its ability to break down cholesterol to a specific bile acid called chenodeoxycholic acid. As a result, a molecule called cholestanol, which is similar to cholesterol, accumulates in xanthomas, blood, nerve cells, and the brain. Cholesterol levels are not increased in the blood, but they are elevated in various tissues throughout the body. The accumulation of cholesterol and cholestanol in the brain, tendons, and other tissues causes the signs and symptoms of cerebrotendinous xanthomatosis.

Read more about the CYP27A1 gene.

How do people inherit cerebrotendinous xanthomatosis?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Where can I find information about treatment for cerebrotendinous xanthomatosis?

These resources address the management of cerebrotendinous xanthomatosis and may include treatment providers.

You might also find information on treatment of cerebrotendinous xanthomatosis in Educational resources and Patient support.

Where can I find additional information about cerebrotendinous xanthomatosis?

You may find the following resources about cerebrotendinous xanthomatosis helpful. These materials are written for the general public.

You may also be interested in these resources, which are designed for healthcare professionals and researchers.

What other names do people use for cerebrotendinous xanthomatosis?

  • CTX
  • Van Bogaert-Scherer-Epstein Disease
  • Xanthomatosis, Cerebrotendinous

What if I still have specific questions about cerebrotendinous xanthomatosis?

Where can I find general information about genetic conditions?

What glossary definitions help with understanding cerebrotendinous xanthomatosis?

Achilles tendon ; acids ; ataxia ; atrophy ; autosomal ; autosomal recessive ; bile ; cardiovascular ; cataract ; cell ; cholesterol ; chronic ; connective tissue ; dementia ; depression ; digestion ; dysarthria ; enzyme ; gene ; hallucinations ; incidence ; leukodystrophy ; lipid ; metabolism ; molecule ; mutation ; nerve cell ; neurological ; population ; recessive ; seizure ; sign ; sterols ; symptom ; synthesis ; tendon ; tissue ; xanthoma

You may find definitions for these and many other terms in the Genetics Home Reference Glossary.

References (5 links)


The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? in the Handbook.

Reviewed: March 2008
Published: January 12, 2009